![Roelof Rongen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roelof Rongen
Director/Board Member at
GRI BIO, INC.
Net worth: - $ as of 31/08/2026
Profile
Roelof Rongen is the founder of Matinas BioPharma, Inc., founded in 2011, serving as President, Chief Executive Officer & Director.
Mr. Rongen was the founder of Innovative Molecules GmbH, founded in 2019, serving as Chief Executive Officer.
Mr. Rongen is also the founder of Essential Fatty Acid Therapeutics LLC..
Mr. Rongen is Chief Executive Officer & Director at Adolore Biotherapeutics, Inc. since 2022.
Mr. Rongen is Independent Director at GRI Bio, Inc. since 2023.
Former positions include Chief Executive Officer & Director at Matinas BioPharma Holdings, Inc. from 2016 to 2018, Executive Director-Marketing at Logistics & Environmental Solutions Corp., Director at Vallon Pharmaceuticals, Inc., Vice President-Life Cycle Management at Reliant Pharmaceuticals LLC from 2000 to 2008, and Executive VP-North American Operations at Trygg Pharma AS from 2009 to 2012.
Education includes undergraduate studies at Wageningen University and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GRI BIO, INC. -.--% | 17/01/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Roelof Rongen active positions
| Companies | Position | Start |
|---|---|---|
| GRI BIO, INC. | Director/Board Member | 24/04/2023 |
Matinas BioPharma, Inc. | Founder | 11/08/2011 |
Essential Fatty Acid Therapeutics LLC | Founder | - |
Adolore Biotherapeutics, Inc.
 Adolore Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing novel therapies for the treatment of chronic, other pain and nervous system | Chief Executive Officer | 01/07/2022 |
Former positions of Roelof Rongen
| Companies | Position | End |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Chief Executive Officer | 16/03/2018 |
Trygg Pharma AS
 Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Develops marine based omega-3 fatty acids for pharmaceutical applications | Corporate Officer/Principal | 01/01/2012 |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2008 |
Innovative Molecules GmbH
 Innovative Molecules GmbH Pharmaceuticals: MajorHealth Technology Provides drug development services | Chief Executive Officer | - |
| GRI BIOPAR | Director/Board Member | - |
Training of Roelof Rongen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
50
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Matinas BioPharma, Inc. | |
Matinas BioPharma Holdings, Inc.
 Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Logistics & Environmental Solutions Corp.
 Logistics & Environmental Solutions Corp. Air Freight/CouriersTransportation Provides logistics solutions for government and commercial markets | Transportation |
Trygg Pharma AS
Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Develops marine based omega-3 fatty acids for pharmaceutical applications | Health Technology |
Wageningen University
 Wageningen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essential Fatty Acid Therapeutics LLC | |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Innovative Molecules GmbH
Innovative Molecules GmbH Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
Adolore Biotherapeutics, Inc.
Adolore Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing novel therapies for the treatment of chronic, other pain and nervous system | Health Technology |
GRI Bio, Inc.
 GRI Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory, fibrotic and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Roelof Rongen
